Bloomberg News

Novacap Buys Salicylic and Paracetamol Activities From Rhodia

November 02, 2011

Nov. 2 (Bloomberg) -- Novacap, a French chemicals maker partly owned by Axa Private Equity, said it bought the salicylic and paracetamol activities of Solvay SA’s Rhodia for an undisclosed sum.

To contact the editor responsible for this story: Francois de Beaupuy at fdebeaupuy@bloomberg.net


American Apparel's Future
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus